Daily Stock Analysis, ANIP, ANI Pharmaceuticals Inc, priceseries

ANI Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
66.00
Close
66.27
High
67.65
Low
65.10
Previous Close
66.25
Daily Price Gain
0.02
YTD High
74.70
YTD High Date
Nov 24, 2017
YTD Low
42.23
YTD Low Date
Aug 9, 2017
YTD Price Change
5.00
YTD Gain
8.16%
52 Week High
74.70
52 Week High Date
Nov 24, 2017
52 Week Low
42.23
52 Week Low Date
Aug 9, 2017
52 Week Price Change
6.59
52 Week Gain
11.04%
Company Information
Stock Symbol
ANIP
Exchange
NasdaqGM
Company URL
http://www.anipharmaceuticals.com
Company Phone
2186343500
CEO
Arthur S. Przybyl
Headquarters
Minnesota
Business Address
210 MAIN STREET WEST, BAUDETTE, MN 56623
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001023024
About

ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Description

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. It focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. The company offers Erythromycin Ethylsuccinate to treat infections; Esterified Estrogen with Methyltestosterone for treating vasomotor symptoms of menopause; Etodolac to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Fenofibrate for treating hypercholesterolemia; Flecainide to treat arrhythmia; Fluvoxamine for treating obsessive-compulsive and social anxiety disorders; and Hydrocortisone Enema and Cortenema to treat ulcerative colitis. It also provides Hydrocortisone Rectal Cream to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Lithium Carbonate ER and Lithobid for bipolar disorder; Mesalamine Enema to treat distal ulcerative colitis, proctosigmoiditis, or proctitis; Methazolamide to treat ocular conditions; and Metoclopramide and Reglan to treat gastroesophageal reflux. In addition, the company offers Nilutamide to treat metastatic prostate cancer; Nimodipine that reduces the ischemic deficits in patients with subarachnoid hemorrhage; Opium Tincture to treat diarrhea; Oxycodone capsules and oral solution for pain; Propafenone to treat arrhythmia; Propranolol ER and Inderal LA for managing hypertension in patients with angina pectoris; and Vancomycin and Vancocin for use in treating C. difficile-associated diarrhea and enterocolitis. Further, it provides contract manufacturing services for other pharmaceutical companies. The company markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota.